Company Overview and News

 
A celebrity planner's world comes crashing down over risible advice

18h theage.com.au
High flying celebrity financial planner Sam Henderson's world came crashing down on Tuesday as the banking royal commission heard he instructed his employees to impersonate a client, misrepresented his tertiary qualifications, failed to disclose a conflict of interest and gave advice to one client that was described as "risible".
Upvote Downvote

 
A celebrity planner's world comes crashing down over risible advice

18h smh.com.au
High flying celebrity financial planner Sam Henderson's world came crashing down on Tuesday as the banking royal commission heard he instructed his employees to impersonate a client, misrepresented his tertiary qualifications, failed to disclose a conflict of interest and gave advice to one client that was described as "risible".
Upvote Downvote

 
ASX finishes flat on banks

2018-04-17 theage.com.au
The Australian market ended flat on Tuesday, with the benchmark once again failing to stretch to a third consecutive session of gains.
Upvote Downvote

 
ASX finishes flat on banks

2018-04-17 smh.com.au
The Australian market ended flat on Tuesday, with the benchmark once again failing to stretch to a third consecutive session of gains.
Upvote Downvote

 
Australian shares seal worst March quarter since financial crisis

2018-03-29 theage.com.au
Australian shares on Thursday wrapped up their worst March quarter performance since the GFC on a suitably sour note despite a modest rebound in the major banks.
Upvote Downvote

 
Australian shares seal worst March quarter since financial crisis

2018-03-29 smh.com.au
Australian shares on Thursday wrapped up their worst March quarter performance since the GFC on a suitably sour note despite a modest rebound in the major banks.
Upvote Downvote

 
Female ASX 200 board appointments spike

2018-03-08 theage.com.au
The percentage of female board appointments has spiked at the start of 2018, but further momentum will be crucial in order to reach a target of 30 per cent female representation for Australia's top 200 companies by the end of the year.
Upvote Downvote

 
HBF to merge with insurance giant to create $4 billion health fund

2018-02-19 abc.net.au
Western Australia's largest heath insurer, HBF, says a planned merger with a big not-for-profit health fund on the east coast of Australia will make the company one of the nation's biggest health funds.
Upvote Downvote

 
HBF enters talks with HCF for health insurance merger

2018-02-16 perthnow.com.au
WA’S BIGGEST private health insurer HBF is in talks over a merger with east coast rival HCF.
Upvote Downvote

 
ASX dips into the red at the end of a positive week

2018-02-16 smh.com.au
The ASX wrapped up a positive week with a small loss on Friday, as financials and miners weighed on the index at the end of another busy week for company earnings.
Upvote Downvote

 
S&P/ASX 200 loses early gains to close 5 points down

2018-02-16 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) remained mostly unchanged on Friday, closing -0.08% down at 5904, held back by falls in the financial, materials and energy sectors.
Upvote Downvote

 
S&P/ASX 200 gives back most of its morning gains

2018-02-16 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) remains slightly up for the day but has trended lower from its morning highs.
Upvote Downvote

 
Health insurance arm buoys Medibank profit

2018-02-16 businessnews.com.au
Medibank Private's turnaround strategy is beginning to pay off with the rate of customer declines slowing and company costs narrowing.  The health insurer has booked a 5.9 per cent increase in half-year profit to $245.6 million thanks to improved operating profit in its Health Insurance and Medibank Health businesses, and allowing it to increase its interim dividend to 5.5 cents, from 5.25 cent a year ago.
Upvote Downvote

 
Medibank makes $20 million investment to hang on to its customers

2018-02-16 smh.com.au
Health insurance giant Medibank Private is launching a priority program to reward its longer-term customers in a bid to stem the number of Australians ditching their hospital cover.
Upvote Downvote

 
S&P/ASX 200 opens strongly continuing its recent form, Star getting sold off heavily

2018-02-16 proactiveinvestors.com.au
S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) opened higher this morning and is currently up 0.3% or 17 points to 5,926.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...